XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.20.2

Supplemental Disclosure of Cash Flow Information | 9 Months Ended
--- | ---
Sep. 30, 2020
Supplemental Cash Flow Elements [Abstract] |
Supplemental Disclosure of Cash Flow Information | Supplemental Disclosure of Cash Flow Information
| Nine Months Ended September 30,
(in thousands) | 2020 |  | 2019
Supplemental Disclosure of Cash Flow Information: |  |  |
Interest paid | $ | 157,688 |  |  | $ | 185,722 |
Income taxes paid, net of refunds | 4,236 |  |  | 1,909 |
Capital expenditures, net of related payables: |  |  |
Capital expenditures - non-development, net | $ | 104,949 |  |  | $ | 180,187 |
Capital expenditures - development, net | 9,913 |  |  | 18,677 |
Capital expenditures - non-development - reimbursable | 17,979 |  |  | 12,043 |
Trade accounts payable | 7,849 |  |  | (4,522) |
Net cash paid | $ | 140,690 |  |  | $ | 206,385 |
Acquisition of communities from Healthpeak: |  |  |
Property, plant and equipment and leasehold intangibles, net | $ | 286,734 |  |  | $ | — |
Operating lease right-of-use assets | (63,285) |  |  | — |
Financing lease obligations | 129,196 |  |  | — |
Operating lease obligations | 74,335 |  |  | — |
Loss (gain) on debt modification and extinguishment, net | (19,731) |  |  | — |
Net cash paid | $ | 407,249 |  |  | $ | — |
Master Agreement with Ventas: |  |  |
Property, plant and equipment and leasehold intangibles, net | $ | (66,444) |  |  | $ | — |
Operating lease right-of-use assets | (153,213) |  |  | — |
Other assets, net | (42,354) |  |  | — |
Long-term debt | 34,053 |  |  | — |
Financing lease obligations | 7,077 |  |  | — |
Operating lease obligations | 362,944 |  |  | — |
Additional paid-in-capital | (22,883) |  |  | — |
Net cash paid | $ | 119,180 |  |  | $ | — |
Acquisition of other assets, net of related payables and cash received: |  |  |
Property, plant and equipment and leasehold intangibles, net | $ | 684 |  |  | $ | — |
Other intangible assets, net | — |  |  | 453 |
Financing lease obligations | 64,260 |  |  | — |
Net cash paid | $ | 64,944 |  |  | $ | 453 |
Proceeds from sale of CCRC Venture, net: |  |  |
Investments in unconsolidated ventures | $ | (14,848) |  |  | $ | — |
Current portion of long-term debt | 34,706 |  |  | — |
Other liabilities | 60,748 |  |  | — |
Loss (gain) on sale of assets, net | (369,831) |  |  | — |
Net cash received | $ | (289,225) |  |  | $ | — |
Proceeds from sale of other assets, net: |  |  |
Prepaid expenses and other assets, net | $ | (1,318) |  |  | $ | (5,298) |
Assets held for sale | (34,348) |  |  | (41,882) |
Property, plant and equipment and leasehold intangibles, net | (938) |  |  | (647) |
Investments in unconsolidated ventures | — |  |  | (156) |
Other liabilities | (1,086) |  |  | (2,724) |
Loss (gain) on sale of assets, net | (4,188) |  |  | (2,723) |
Net cash received | $ | (41,878) |  |  | $ | (53,430) |
Supplemental Schedule of Non-cash Operating, Investing, and Financing Activities: |  |  |
Assets designated as held for sale: |  |  |
Prepaid expenses and other assets, net | $ | — |  |  | $ | (5) |
Assets held for sale | — |  |  | 9,169 |
Property, plant and equipment and leasehold intangibles, net | — |  |  | (9,164) |
Net | $ | — |  |  | $ | — |
Healthpeak master lease modification: |  |  |
Property, plant and equipment and leasehold intangibles, net | $ | (57,462) |  |  | $ | — |
Operating lease right-of-use assets | 88,044 |  |  | — |
Financing lease obligations | 70,874 |  |  | — |
Operating lease obligations | (101,456) |  |  | — |
Net | $ | — |  |  | $ | — |
Other lease termination and modification, net: |  |  |
Prepaid expenses and other assets, net | $ | — |  |  | $ | (648) |
Property, plant and equipment and leasehold intangibles, net | 13,498 |  |  | (1,666) |
Operating lease right-of-use assets | 7,291 |  |  | (8,644) |
Financing lease obligations | (15,483) |  |  | — |
Operating lease obligations | (5,199) |  |  | 9,289 |
Other liabilities | (107) |  |  | (337) |
Loss (gain) on facility lease termination and modification, net | — |  |  | 2,006 |
Net | $ | — |  |  | $ | — |
During the three months ended June 30, 2019, the Company and its joint venture partner contributed cash in an aggregate amount of $13.3 million to a consolidated joint venture which owned three senior housing communities. The Company obtained a $6.6 million promissory note receivable from its joint venture partner secured by a 50% equity interest in the joint venture in a non-cash exchange for the Company funding the $13.3 million aggregate contribution in cash. Restricted cash consists principally of deposits for letters of credit, escrow deposits for real estate taxes, property insurance, and capital expenditures, debt service reserve accounts required by certain lenders under mortgage debt agreements, and deposits as security for self-insured retention risk under workers' compensation programs and property insurance programs. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sums to the total of the same such amounts shown in the condensed consolidated statements of cash flows.
(in thousands) | September 30, 2020 |  | December 31, 2019
Reconciliation of cash, cash equivalents, and restricted cash: |  |  |
Cash and cash equivalents | $ | 354,621 |  |  | $ | 240,227 |
Restricted cash | 35,206 |  |  | 26,856 |
Long-term restricted cash | 103,248 |  |  | 34,614 |
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows | $ | 493,075 |  |  | $ | 301,697 |

X
- Definition The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -URI http://asc.fasb.org/topic&trid=2134446 + Details
Name: | us-gaap_CashFlowSupplementalDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SupplementalCashFlowElementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration